AKT1 and pancreatic neoplasm: FGFR is frequently activated in gastrointestinal cancers, including pancreatic cancer, in both ligand-dependent and ligand-independent manners, leading to activation of downstream pro-survival pathways such as PI3K-AKT and MAPK[16], consistent with our transcriptomic results [Figure 2A].